Potentiation of neuroleptics by catecholamine inhibitors.
D000328:Adult; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D002395:Catecholamines / Q000037:antagonists & inhibitors; D004357:Drug Synergism; D005260:Female; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D008781:Methyltyrosines / Q000009:adverse effects*
D002395:Catecholamines; D008781:Methyltyrosines; D006220:Haloperidol